Molecular imaging probes for 31P contrast

Molecular imaging probes for 31P contrast

<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tear, L
Otros Autores:	Faulkner, S
Formato:	Tesis
Lenguaje:	English
Publicado:	2018
Materias:	Contrast media (Diagnostic imaging) Nuclear magnetic resonance spectroscopy Gadolinium

Ejemplares similares

Magnetic Resonance Imaging Contrast Agents: A Review of Literature
por: Zahra Sahraei, et al.
Publicado: (2015-10-01)

Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
por: Marco Moscatelli, et al.
Publicado: (2023-10-01)

Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
por: Johannes M. Froehlich, et al.
Publicado: (2023-04-01)

Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
por: Nacif Marcelo S, et al.
Publicado: (2012-02-01)

Toxicity associated with gadolinium-based contrast-enhanced examinations
por: Silvia Maria Lattanzio
Publicado: (2021-05-01)

Нas the stability of gadoliniumbased magnetic resonance contrast media the clinical significance?
por: V. O. Panov, et al.
Publicado: (2016-09-01)

Contrast‐Enhanced Cardiac Magnetic Resonance Imaging With a Manganese‐Based Alternative to Gadolinium for Tissue Characterization of Acute Myocardial Infarction
por: Benjamin P. Bonner, et al.
Publicado: (2023-04-01)

Gadolinium retention after contrast-enhanced magnetic resonance imaging: A narrative review
por: Afnan Fahd Al-Muhanna
Publicado: (2022-01-01)

The safety of magnetic resonance imaging contrast agents
por: Amy Cunningham, et al.
Publicado: (2024-08-01)

Novel MR imaging contrast agents for cancer detection
por: Daryoush Shahbazi-Gahrouei
Publicado: (2009-05-01)

Dark-Blood Late Gadolinium Enhancement MRI Is Noninferior to Bright-Blood LGE in Non-Ischemic Cardiomyopathies
por: Jan M. Brendel, et al.
Publicado: (2023-05-01)

THE USE OF INNOVATIVE DOMESTIC CONTRAST AGENT GADOLINIUM-BASED FOR MR-CANCER DIAGNOSIS IN EXPERIMENT
por: V. I. Chernov, et al.
Publicado: (2016-02-01)

Choroid plexus volume in multiple sclerosis can be estimated on structural MRI avoiding contrast injection
por: Valentina Visani, et al.
Publicado: (2024-02-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Atiya Fatima, et al.
Publicado: (2021-09-01)

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection
por: Rong Lu, et al.
Publicado: (2020-12-01)

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances
por: Xiaodong Li, et al.
Publicado: (2020-11-01)

Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
por: S A. Aleksandrova, et al.
Publicado: (2024-12-01)

Dynamic nuclear polarisation as a probe of metabolism in pathophysiology
por: Miller, J
Publicado: (2015)

Gadolinium-Cyclic 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Click-Sulfonyl Fluoride for Probing Serine Protease Activity in Magnetic Resonance Imaging
por: Phuong Tu Huynh, et al.
Publicado: (2023-04-01)

Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study
por: Jarl Åsbjørn Jakobsen, et al.
Publicado: (2021-04-01)

Nephrogenic systemic fibrosis: Current concepts
por: Prasanta Basak, et al.
Publicado: (2011-01-01)

MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?
por: E. S. Kamyshova, et al.
Publicado: (2019-03-01)

Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives
por: Bang J. Guo, et al.
Publicado: (2018-09-01)

Fluorinated Paramagnetic Complexes: Sensitive and Responsive Probes for Magnetic Resonance Spectroscopy and Imaging
por: Katie L. Peterson, et al.
Publicado: (2018-05-01)

Molecular Dynamics Simulations of the Internal Mobility of Gd3+-Based MRI Contrast Agents: Consequences for Water Proton Relaxivity
por: Alain Borel, et al.
Publicado: (2004-04-01)

Absolute quantification of human in vivo hepatic 31P magnetic resonance spectroscopy at 7 tesla
por: Purvis, L
Publicado: (2018)

31P nuclear magnetic resonance study on binary germanium phosphate glasses /
por: 218458 Abdel Wahab Mohamed Ali Hussein, et al.
Publicado: (2002)

Reducing contrast agent residuals in hospital wastewater: the GREENWATER study protocol
por: Moreno Zanardo, et al.
Publicado: (2023-05-01)

Unusual Magnetic Resonance Imaging Findings Contrast-induced Encephalopathy following Cerebral Angiography
por: Won Ho Cho, et al.
Publicado: (2021-12-01)

Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions
por: Wenjie Tang, et al.
Publicado: (2025-02-01)

AI-powered contrast-free cardiovascular magnetic resonance imaging for myocardial infarction
por: Vedat Cicek, et al.
Publicado: (2024-11-01)

A five-year-old boy with anaphylaxis reaction to gadolinium-based MR contrast medium: a case report
por: Seung Hun Woo, et al.
Publicado: (2024-10-01)

Gadolinium-Coated Mesoporous Silica Nanoparticle for Magnetic Resonance Imaging
por: Zhongtao Li, et al.
Publicado: (2022-02-01)

The Effectiveness of Calcium Supplement as Orally Contrast Media for Gastric Magnetic Resonance Imaging
por: Zainab Abdulla Mankhi, et al.
Publicado: (2024-10-01)

Heavily Gd-Doped Non-Toxic Cerium Oxide Nanoparticles for MRI Labelling of Stem Cells
por: Anton L. Popov, et al.
Publicado: (2023-01-01)

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance
por: Neil Zaki, et al.
Publicado: (2020-12-01)

Liver function assessment based on hepatobiliary contrast agent-enhanced magnetic resonance imaging
por: Sofiia F. Ageeva, et al.
Publicado: (2024-09-01)

Contrast Medium Hypersensitivity: A Large Italian Study with Long-Term Follow-Up
por: Eleonora Nucera, et al.
Publicado: (2022-03-01)

3D MR neurography with gadolinium contrast to improve the visualization of pelvic nerves and the branches
por: Hui Liu, et al.
Publicado: (2024-05-01)

Spinal Cerebrospinal Fluid Leakage in Spontaneous Intracranial Hypotension: An Intrathecal Gadolinium Enhanced MR-Myelography Study
por: Hakan Cebeci, et al.
Publicado: (2020-01-01)